Acute Respiratory Insufficiency
12
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Ultrasound Scoring Methods to Monitor Breathing Problems in Intensive Care Patients
Respiratory Variability in Patients With Acute Hypoxemic Respiratory Failure and Placed on High Flow Oxygen Therapy
Ventilation Strategies During Spontaneous Breathing Trial
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy
NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency
Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.
Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic